Skip to main content
OSTEOPORE LIMITED logo

OSTEOPORE LIMITED — Investor Relations & Filings

Ticker · OSX ISIN · AU0000053324 ASX Manufacturing
Open in API
Filings indexed 486 across all filing types
Latest filing 2025-05-22 Capital/Financing Update
Country AU Australia
Listing ASX OSX

About OSTEOPORE LIMITED

https://osteopore.com

Osteopore Limited specializes in the design and manufacture of 3D-printed bioresorbable implants. The company utilizes a patented 3D printing process to create scaffolds from bioresorbable polymers, such as polycaprolactone, designed to mimic the natural microstructure of bone. These implants, including the Osteoplug, Osteomesh, and Osteostrip product lines, are applied in neurosurgical, craniofacial, and orthopedic procedures to facilitate bone healing and tissue regeneration. The scaffolds provide a temporary structural framework that supports the body's natural healing process before being gradually absorbed and replaced by the patient's own bone tissue. This technology aims to reduce long-term complications associated with permanent foreign implants by promoting natural tissue integration and restoration across various clinical applications.

Recent filings

Filing Released Lang Actions
Further Drawdown of T1 of the Redeemable Convertible Notes 3 pages 368.0KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 23 May 2025 regarding further drawdown of Tranche 1 of redeemable convertible notes by Osteopore Limited. It details subscription agreements, amounts raised, and use of funds. There are no financial statements or detailed financial analysis included, only an update on financing activities. The document is not a full financial report, earnings release, or management discussion. It is clearly an update on the company's capital raising and financing activities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is 5251 characters, sufficient to contain substantive information about financing but not a full report.
2025-05-22 English
Cleansing Notice - Convertible Notes 20 pages 720.3KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 23 May 2025 regarding a Cleansing Notice for the issuance of a subsequent tranche of convertible notes by Osteopore Limited. It references the Corporations Act 2001 and details the terms, effects on capital structure, and rights attached to the convertible notes and resulting shares. The document includes pro forma financial information illustrating the impact of the convertible notes issuance but does not contain full audited financial statements or comprehensive financial performance data. The primary purpose is to provide regulatory disclosure about a capital raising event involving convertible notes, enabling resale of shares issued on conversion without further disclosure. This fits the definition of a Capital/Financing Update (CAP) as it updates on company fundraising and capital structure changes. The document is lengthy (15,000 characters) and detailed, not a brief announcement or certification, so it is not RPA or RNS. Therefore, the correct classification is CAP with high confidence.
2025-05-22 English
Notification regarding unquoted securities - OSX 6 pages 18.8KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of convertible notes by Osteopore Limited. It includes specifics such as the number of securities issued, issue price, purpose (to raise additional working capital), and compliance with ASX listing rules. The content focuses on the announcement of new securities issued and related details rather than a full financial report or earnings release. This matches the definition of a Share Issue/Capital Change announcement, which covers new share issues or capital changes. The document length (5625 characters) and detailed issuance information support this classification rather than a brief report publication or regulatory filing. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2025-05-22 English
Further Drawdown of T1 of the Redeemable Convertible Notes 3 pages 364.4KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 16 May 2025 regarding a further drawdown of tranche 1 of redeemable convertible notes by Osteopore Limited. It details the subscription agreement, the amounts subscribed in various sub-tranches, and the intended use of funds. There are no financial statements or detailed financial analysis included, only an update on financing activity. The document is not a full financial report, earnings release, or management discussion. It is clearly an update on the company's capital raising activities through convertible notes issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (5058 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2025-05-15 English
Cleansing Notice - Convertible Notes 20 pages 702.1KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 16 May 2025 regarding a Cleansing Notice for the issue of a subsequent tranche of convertible notes by Osteopore Limited. It details the terms of the convertible notes, the effect on the company's capital structure, pro forma financial position, and rights attaching to shares issued upon conversion. The document is a regulatory announcement about a capital raising and convertible note issuance, including pro forma financial information but not a full financial report. It is not an annual or interim report, earnings release, or management discussion. It is not a proxy, voting result, or governance document. The primary purpose is to provide notice and details about the convertible notes issuance and its impact on capital structure and financial position. This fits the definition of a Capital/Financing Update (CAP). The document length is substantial and contains detailed financial and capital structure information related to financing activities, supporting a high confidence classification as CAP.
2025-05-15 English
Notification regarding unquoted securities - OSX 6 pages 18.8KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of convertible notes by Osteopore Limited. It includes specifics such as the number of securities issued, issue price, purpose (to raise working capital), and compliance with ASX listing rules. This is a clear announcement of a capital raising event involving new securities issuance. It is not a full financial report, audit, or management discussion, nor is it a voting result or AGM material. The content fits the definition of a Capital/Financing Update, which covers company fundraising and capital structure changes.
2025-05-15 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.